Karolinska Institutet
As one of the world’s foremost medical universities, KI accounts for the single largest share of all academic medical research conducted in Sweden. KI also offers the country’s broadest range of education in medicine and health sciences.
Press invitation: Apply for accreditation for the announcement of the 2026 Nobel Prize in Physiology or Medicine on 5 October
The announcement will be open only for media representatives who have been accredited in advance. Please note that a registration beforehand and valid press credentials (also for accompanying colleagues) are mandatory. In addition to a press ID, you must bring a valid photo ID (driving license, passport or other equivalent). Read more and register by 1 October.
Experience Nobel Calling at KI
A warm welcome to KI’s new students
Ahead of the autumn term 2026, KI’s new students were welcomed with a week filled with inspiration, community and engagement. As early as the week before the start of term, new students had the opportunity to get to know both KI and each other through lectures, activities and meetings with different parts of student life.
New student: All you need to know for the autumn term 2026
We are happy that you have chosen to study with us at KI. Here you will find useful information, helpful tips, and fun activities to help you prepare for the start of your studies. See you this autumn!
From Italy to KI – Paolo wants to contribute to future cancer treatments
Paolo Ceriani has always been interested in science, but when his mother was diagnosed with cancer, that interest took a new direction. He wanted to understand the disease on a deeper level and later began studying Biomedicine at Karolinska Institutet. Before moving to Sweden, he had only visited the country once – on a road trip from Italy through northern Sweden.
News and updates from the University Management
Working at KI
The Nobel Prize in Physiology or Medicine
Support research and education
Core facilities
International collaboration
University Library (KIB)
KI in brief